A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors

Clinical trial NCT00975182 · COMPLETED

Trial details

NCT number: NCT00975182
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Squamous Non-Small Cell Lung Cancer, Solid Cancers

Start date: 2009-09-01
Primary completion: 2014-09-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.